At a glance
ClinicalIndex Comparison RecordN/ACompleted· 121 enrolled
Drug / intervention
Immediate Antibiotics +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics (Pilot)
University of Washington, the Collaborative Health Studies Coordinating Center·interventional·Posted Oct 29, 2020·Updated Oct 18, 2024
In Brief
A clinical study evaluating Immediate Antibiotics and Tailored Treatment for Cystic Fibrosis. Completed, enrolled 121 participants across 10 sites.
Detailed Summary
STOP PEDS is a pilot study of children with CF ages 6-18 across 10 sites in North America. The primary goal is to assess the acceptability and feasibility of a multicenter randomized trial comparing immediate antibiotics versus tailored therapy for pulmonary exacerbation (PEx) treatment in this population.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCystic Fibrosis
CountriesUnited States
CollaboratorsCystic Fibrosis Foundation
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedOct 2020
Enrollment StartNov 2020
Primary CompletionAug 2022
TodayJul 2026
First PostedOct 29, 2020
Enrollment StartNov 10, 2020
Primary CompletionAug 18, 2022
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 5.7 years ago
Interventions
Immediate Antibioticsother
increase airway clearance/start oral antibiotics right away
Tailored Treatmentother
increase airway clearance and start oral antibiotics later if symptoms get worse or do not get better